Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Musculoskeletal
 Disease Category: Leukemia
Location: United States, WV

Trial Information

S0535 - A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated, High-Risk Acute Promyelocytic Leukemia

Objective is to assess the event-free survival and death during the first six weeks in patients treated with a combined regimen of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin, to estimate the frequency and severity of toxicities and to investigate the molecular response rate.

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South, PO Box 9260
Morgantown, WV 26506
Phone: 304-293-4944

View Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.